Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Gate for Bacterial Toxins Found

16.04.2014

Freiburg researchers discover a molecule that smuggles toxins from intestinal pathogens into human cells

Prof. Dr. Dr. Klaus Aktories and Dr. Panagiotis Papatheodorou from the Institute of Experimental and Clinical Pharmacology and Toxicology of the University of Freiburg have discovered the receptor responsible for smuggling the toxin of the bacterium Clostridium perfringens into the cell.


The cell of the host absorbs the clostridium perfringens toxin TpeL via the receptor LRP1. The toxins then destroy the cell from within. (left: cell culture without toxins; right: cell culture after toxins were applied). Source: Panagiotis Papatheodorou

The TpeL toxin is formed by C. perfringens, a pathogen that causes gas gangrene and food poisoning. It is very similar to the toxins of many other hospital germs of the genus Clostridium. The toxins bind to surface molecules and creep into the body cell, where they lead to cell death.

“In order to prevent the toxin from entering the cell, it is necessary to find the receptor that serves as the gatekeeper. But the search for this key molecule remained unsuccessful for a long time,” says Aktories, member of the Cluster of Excellence BIOSS Centre for Biological Signalling Studies. In cooperation with colleagues from Düsseldorf, the USA, and the Netherlands, the researchers from Freiburg have now identified a receptor for a clostridial toxin of this type for the first time ever.

Their findings were published in the journal Proceedings of the National Academy of Sciences (PNAS).

Clostridia cause intestinal and wound diseases in humans and animals that are often fatal. “At the moment, infections with the bacterium Clostridium difficile are particularly problematic in hospitals. The diseases tend to appear following treatment with antibiotics and often lead to diarrhea, but also to fatal inflammations of the bowels,” explains Aktories.

The toxins force their way into host cells and deactivate signaling molecules by attaching a sugar molecule to these cellular switches. Once this signaling pathway has been switched off, the cell dies – infested tissue dies off.

In order to find the receptor, the researchers applied a genetic selection procedure, a so-called screening, in which individual genes in cells from human cancer cell lines are turned off at random. This procedure led to the discovery that cells are immune to the TpeL toxin when the gene for the protein LRP1 is switched off on the cell surface.

LRP1, which stands for low density lipoprotein receptor-related protein 1, usually takes in proteins that serve as a means of transport for lipids in the blood. The researchers demonstrate that LRP1 is the long sought-after key molecule: It also regulates the intake of the toxin TpeL.

His team also proposes a new model, explains Aktories: “Our findings indicate that two receptors are involved in the effect of the other sugar-carrying clostridial toxins.” Researchers can use the findings to develop new agents against clostridia. “Our discovery will also provide new impetus for researchers to identify further toxin receptors,” Aktories hopes.

Original publication:
LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins. Björn Schorch, Shuo Song, Ferdy R. van Diemen, Hans H. Bock, Petra May, Joachim Herz, Thijn R. Brummelkamp, Panagiotis Papatheodorou, and Klaus Aktories. PNAS 2014; published ahead of print April 15, 2014, doi:10.1073/pnas.1323790111 

Contact:
Prof. Dr. Dr. Klaus Aktories
Institute of Experimental and Clinical Pharmacology and Toxicology
University of Freiburg
Phone: +49 (0)761/203-5308
E-Mail: klaus.aktories@pharmakol.uni-freiburg.de

Prof. Dr. Dr. Klaus Aktories | University of Freiburg
Further information:
http://www.uni-freiburg.de

Further reports about: Clostridium PNAS Panagiotis Toxicology bacterium diseases explains genes poisoning procedure proteins receptor toxins

More articles from Life Sciences:

nachricht Not of Divided Mind
19.01.2017 | Hertie-Institut für klinische Hirnforschung (HIH)

nachricht CRISPR meets single-cell sequencing in new screening method
19.01.2017 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>